Cargando…

A ferroptosis-related lncRNA signature predicts prognosis in ovarian cancer patients

BACKGROUND: Ovarian cancer (OC) is a common gynecological malignant tumor with poor prognosis. Ferroptosis is an iron-dependent modality of regulated cell death. The purpose of this study was to determine the prognostic ability of ferroptosis-related long non-coding RNAs (lncRNAs) in OC patients and...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Jing, Hao, Yan, Rao, Bihua, Zhang, Zhiguo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797490/
https://www.ncbi.nlm.nih.gov/pubmed/35116333
http://dx.doi.org/10.21037/tcr-21-1152
_version_ 1784641565670506496
author Peng, Jing
Hao, Yan
Rao, Bihua
Zhang, Zhiguo
author_facet Peng, Jing
Hao, Yan
Rao, Bihua
Zhang, Zhiguo
author_sort Peng, Jing
collection PubMed
description BACKGROUND: Ovarian cancer (OC) is a common gynecological malignant tumor with poor prognosis. Ferroptosis is an iron-dependent modality of regulated cell death. The purpose of this study was to determine the prognostic ability of ferroptosis-related long non-coding RNAs (lncRNAs) in OC patients and construct a ferroptosis-related lncRNA prognostic model. METHODS: The Cancer Genome Atlas (TCGA) and FerrDb databases were used to collect RNA sequencing data of OC patients and ferroptosis-related genes, respectively. OC patients were randomly assigned to the training or testing set. Pearson correlation analysis was used to identify ferroptosis-related lncRNAs. Univariate Cox, Least Absolute Shrinkage and Selection Operator (LASSO), and multivariate regression analyses were performed in the training set to develop a predictive model. The model was validated in the testing set and entire set. Survival analysis, receiver operating characteristic curves, independent prognostic factor analysis, and correlation analysis with clinical features were performed to evaluate the predictive value of the model. A nomogram was established to predict the survivability of OC patients over 1, 3, and 5 years. The distribution of distinct groups was investigated using principal component analysis, and the underlying the biological functions were explored using gene set enrichment analysis. RESULTS: Eleven ferroptosis-related lncRNAs were determined to establish the prognostic model. Patients in the high-risk group had poor prognosis compared with the low-risk group in the training, testing and entire sets. The area under the receiver operating characteristic curve corresponding to 1-, 3-, and 5-year survival were 0.731, 0.796, and 0.805 in the training set; 0.704, 0.597, and 0.655 in the testing set; and 0.715, 0.691, and 0.736, in the entire set, respectively. The risk score correlated with age and grade. The risk score was also an independent prognostic factor in OC. A nomogram with high C-index (0.68) was constructed. An intuitive observation of the principal component analysis revealed a distinction between high- and low-risk groups, and gene set enrichment analysis indicated that cancer-related pathways were enriched in the high-risk group. CONCLUSIONS: The signature composed of 11 ferroptosis-related lncRNAs accurately predicted the prognosis of OC patients.
format Online
Article
Text
id pubmed-8797490
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-87974902022-02-02 A ferroptosis-related lncRNA signature predicts prognosis in ovarian cancer patients Peng, Jing Hao, Yan Rao, Bihua Zhang, Zhiguo Transl Cancer Res Original Article BACKGROUND: Ovarian cancer (OC) is a common gynecological malignant tumor with poor prognosis. Ferroptosis is an iron-dependent modality of regulated cell death. The purpose of this study was to determine the prognostic ability of ferroptosis-related long non-coding RNAs (lncRNAs) in OC patients and construct a ferroptosis-related lncRNA prognostic model. METHODS: The Cancer Genome Atlas (TCGA) and FerrDb databases were used to collect RNA sequencing data of OC patients and ferroptosis-related genes, respectively. OC patients were randomly assigned to the training or testing set. Pearson correlation analysis was used to identify ferroptosis-related lncRNAs. Univariate Cox, Least Absolute Shrinkage and Selection Operator (LASSO), and multivariate regression analyses were performed in the training set to develop a predictive model. The model was validated in the testing set and entire set. Survival analysis, receiver operating characteristic curves, independent prognostic factor analysis, and correlation analysis with clinical features were performed to evaluate the predictive value of the model. A nomogram was established to predict the survivability of OC patients over 1, 3, and 5 years. The distribution of distinct groups was investigated using principal component analysis, and the underlying the biological functions were explored using gene set enrichment analysis. RESULTS: Eleven ferroptosis-related lncRNAs were determined to establish the prognostic model. Patients in the high-risk group had poor prognosis compared with the low-risk group in the training, testing and entire sets. The area under the receiver operating characteristic curve corresponding to 1-, 3-, and 5-year survival were 0.731, 0.796, and 0.805 in the training set; 0.704, 0.597, and 0.655 in the testing set; and 0.715, 0.691, and 0.736, in the entire set, respectively. The risk score correlated with age and grade. The risk score was also an independent prognostic factor in OC. A nomogram with high C-index (0.68) was constructed. An intuitive observation of the principal component analysis revealed a distinction between high- and low-risk groups, and gene set enrichment analysis indicated that cancer-related pathways were enriched in the high-risk group. CONCLUSIONS: The signature composed of 11 ferroptosis-related lncRNAs accurately predicted the prognosis of OC patients. AME Publishing Company 2021-11 /pmc/articles/PMC8797490/ /pubmed/35116333 http://dx.doi.org/10.21037/tcr-21-1152 Text en 2021 Translational Cancer Research. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.
spellingShingle Original Article
Peng, Jing
Hao, Yan
Rao, Bihua
Zhang, Zhiguo
A ferroptosis-related lncRNA signature predicts prognosis in ovarian cancer patients
title A ferroptosis-related lncRNA signature predicts prognosis in ovarian cancer patients
title_full A ferroptosis-related lncRNA signature predicts prognosis in ovarian cancer patients
title_fullStr A ferroptosis-related lncRNA signature predicts prognosis in ovarian cancer patients
title_full_unstemmed A ferroptosis-related lncRNA signature predicts prognosis in ovarian cancer patients
title_short A ferroptosis-related lncRNA signature predicts prognosis in ovarian cancer patients
title_sort ferroptosis-related lncrna signature predicts prognosis in ovarian cancer patients
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797490/
https://www.ncbi.nlm.nih.gov/pubmed/35116333
http://dx.doi.org/10.21037/tcr-21-1152
work_keys_str_mv AT pengjing aferroptosisrelatedlncrnasignaturepredictsprognosisinovariancancerpatients
AT haoyan aferroptosisrelatedlncrnasignaturepredictsprognosisinovariancancerpatients
AT raobihua aferroptosisrelatedlncrnasignaturepredictsprognosisinovariancancerpatients
AT zhangzhiguo aferroptosisrelatedlncrnasignaturepredictsprognosisinovariancancerpatients
AT pengjing ferroptosisrelatedlncrnasignaturepredictsprognosisinovariancancerpatients
AT haoyan ferroptosisrelatedlncrnasignaturepredictsprognosisinovariancancerpatients
AT raobihua ferroptosisrelatedlncrnasignaturepredictsprognosisinovariancancerpatients
AT zhangzhiguo ferroptosisrelatedlncrnasignaturepredictsprognosisinovariancancerpatients